No sabemos si la última respuesta a esta solicitud contiene información o no – si eres Dalila M. Olmo López por favor abre una sesión y háznoslo saber.

Agreement between the European Union and the United States of America to enhance the COVID-19 vaccination production and immunize third world countries

Estamos a la espera de que Dalila M. Olmo López lea una respuesta reciente y de que actualice el estado.

Dear European Medicines Agency,

Under the right of access to documents in the EU treaties, as developed in Regulation 1049/2001, I am requesting documents which contain the following information:

I would like to have access to all the documents related to the agreement between the European Union and the United States of America to enhance the COVID-19 vaccination production and immunize third world countries.

The joint agreement was announced on March 9 of 2021 by the Commission of Europe and was in a meeting between the European Commissioner for the Internal Market and Head of the European Task Force on Vaccine Production, Thierry Breton, and the White House Covid-19 Response Coordinator, Jeffrey Zients.

Yours faithfully,

Dalila M. Olmo López

Agencia Europea de Medicamentos

2 Adjuntos

  • Attachment

    attachment.delivery status

    0K Download

  • Attachment

    access to documents request Agreement between the European Union and the United States of America to enhance the COVID 19 vaccination production and immunize third world countries.txt

    1K Download View as HTML

Delivery has failed to these recipients or groups:

[1]documents requests at EMA ([EMA request email])
The email address you entered couldn't be found. Please check the
recipient's email address and try to resend the message. If the problem
continues, please contact your helpdesk.

Diagnostic information for administrators:

Generating server: wv1277.emea.eu.int

[EMA request email]
Remote Server returned '550 5.1.1 RESOLVER.ADR.RecipNotFound; not found'

Original message headers:

Received: from wv1275.emea.eu.int (172.16.91.20) by wv1277.emea.eu.int
(172.16.91.22) with Microsoft SMTP Server (TLS) id 15.0.1497.24; Thu, 11 Nov
2021 18:53:15 +0100
Received: from mail6.bemta34.messagelabs.com (172.16.40.221) by
wv1275.emea.eu.int (172.16.91.20) with Microsoft SMTP Server (TLS) id
15.0.1497.24 via Frontend Transport; Thu, 11 Nov 2021 18:53:15 +0100
Return-Path: <[FOI #10209 email]>
Received: from [100.115.34.161] (using TLSv1.2 with cipher DHE-RSA-AES256-GCM-SHA384 (256 bits))
by server-1.bemta.az-a.eu-west-2.aws.ess.symcld.net id 04/4A-17169-B885D816; Thu, 11 Nov 2021 17:53:15 +0000
Authentication-Results: mx.messagelabs.com; spf=pass
(server-21.tower-584.messagelabs.com: domain of asktheeu.org designates
46.43.39.108 as permitted sender) smtp.mailfrom=asktheeu.org; dkim=none
(message not signed); dmarc=none (no record) header.from=asktheeu.org
X-Brightmail-Tracker: H4sIAAAAAAAAA+NgFvrPLMWRWlGSWpSXmKPExsWip62eo9sV0Zt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X-Env-Sender: [FOI #10209 email]
X-Msg-Ref: server-21.tower-584.messagelabs.com!1636653194!432023!1
X-Originating-IP: [46.43.39.108]
X-SpamReason: No, hits=0.0 required=7.0 tests=newsletters:
X-StarScan-Received:
X-StarScan-Version: 9.81.5; banners=-,-,-
X-VirusChecked: Checked
Received: (qmail 31310 invoked from network); 11 Nov 2021 17:53:14 -0000
Received: from owl.ukcod.org.uk (HELO owl.ukcod.org.uk) (46.43.39.108)
by server-21.tower-584.messagelabs.com with ECDHE-RSA-AES256-GCM-SHA384 encrypted SMTP; 11 Nov 2021 17:53:14 -0000
Received: from foieu by owl.ukcod.org.uk with local (Exim 4.89)
(envelope-from <[FOI #10209 email]>)
id 1mlEGA-0001ud-AN
for [EMA request email]; Thu, 11 Nov 2021 17:53:14 +0000
Date: Thu, 11 Nov 2021 17:53:14 +0000
From: =?UTF-8?B?RGFsaWxhIE0uIE9sbW8gTMOzcGV6?=
<[FOI #10209 email]>
To: documents requests at EMA <[EMA request email]>
Message-ID: <[email address]>
Subject: access to documents request - Agreement between the European Union
and the United States of America to enhance the COVID-19 vaccination
production and immunize third world countries
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

References

Visible links
1. mailto:[EMA request email]

Dear European Medicines Agency,

I see you are having problems with sending information to my email. Please try again with [email address] or try this other email [email address].

Yours faithfully,
Dalila M. Olmo López

Agencia Europea de Medicamentos

2 Adjuntos

  • Attachment

    attachment.delivery status

    0K Download

  • Attachment

    Internal review of access to documents request Agreement between the European Union and the United States of America to enhance the COVID 19 vaccination production and immunize third world countries.txt

    4K Download View as HTML

Delivery has failed to these recipients or groups:

[1]documents requests at EMA ([EMA request email])
The email address you entered couldn't be found. Please check the
recipient's email address and try to resend the message. If the problem
continues, please contact your helpdesk.

Diagnostic information for administrators:

Generating server: wv1275.emea.eu.int

[EMA request email]
Remote Server returned '550 5.1.1 RESOLVER.ADR.RecipNotFound; not found'

Original message headers:

Received: from wv1275.emea.eu.int (172.16.91.20) by wv1275.emea.eu.int
(172.16.91.20) with Microsoft SMTP Server (TLS) id 15.0.1497.24; Wed, 17 Nov
2021 17:28:45 +0100
Received: from mail6.bemta25.messagelabs.com (172.16.40.221) by
wv1275.emea.eu.int (172.16.91.20) with Microsoft SMTP Server (TLS) id
15.0.1497.24 via Frontend Transport; Wed, 17 Nov 2021 17:28:45 +0100
Return-Path: <[FOI #10209 email]>
Received: from [100.112.197.207] (using TLSv1.2 with cipher DHE-RSA-AES256-GCM-SHA384 (256 bits))
by server-4.bemta.az-b.eu-west-1.aws.symcld.net id 30/52-08711-CBD25916; Wed, 17 Nov 2021 16:28:44 +0000
Authentication-Results: mx.messagelabs.com; spf=pass
(server-2.tower-284.messagelabs.com: domain of asktheeu.org designates
46.43.39.108 as permitted sender) smtp.mailfrom=asktheeu.org; dkim=none
(message not signed); dmarc=none (no record) header.from=asktheeu.org
X-Brightmail-Tracker: H4sIAAAAAAAAA+NgFupkkeJIrShJLcpLzFFi42LR01bP0d2jOzX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X-Env-Sender: [FOI #10209 email]
X-Msg-Ref: server-2.tower-284.messagelabs.com!1637166523!125978!1
X-Originating-IP: [46.43.39.108]
X-SpamReason: No, hits=0.0 required=7.0 tests=newsletters: ,
MAILTO_TO_SPAM_ADDR
X-StarScan-Received:
X-StarScan-Version: 9.81.5; banners=-,-,-
X-VirusChecked: Checked
Received: (qmail 22566 invoked from network); 17 Nov 2021 16:28:44 -0000
Received: from owl.ukcod.org.uk (HELO owl.ukcod.org.uk) (46.43.39.108)
by server-2.tower-284.messagelabs.com with ECDHE-RSA-AES256-GCM-SHA384 encrypted SMTP; 17 Nov 2021 16:28:44 -0000
Received: from foieu by owl.ukcod.org.uk with local (Exim 4.89)
(envelope-from <[FOI #10209 email]>)
id 1mnNnf-0006aC-KF
for [EMA request email]; Wed, 17 Nov 2021 16:28:43 +0000
Date: Wed, 17 Nov 2021 16:28:43 +0000
From: =?UTF-8?B?RGFsaWxhIE0uIE9sbW8gTMOzcGV6?=
<[FOI #10209 email]>
To: documents requests at EMA <[EMA request email]>
Message-ID: <[email address]>
Subject: Internal review of access to documents request - Agreement between
the European Union and the United States of America to enhance the COVID-19
vaccination production and immunize third world countries
MIME-Version: 1.0
Content-Type: text/plain; charset="UTF-8"
Content-Transfer-Encoding: quoted-printable

References

Visible links
1. mailto:[EMA request email]

No sabemos si la última respuesta a esta solicitud contiene información o no – si eres Dalila M. Olmo López por favor abre una sesión y háznoslo saber.